Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
01 1Ofichem BV
02 1Andhra Organics Limited
03 1Fagron Services BV
04 1Hunan Xiangyikang Pharmaceutical Co., Ltd.
05 1Kalchem International inc
06 1Medisca Inc
07 2Medisca Inc.
08 1NANHAI BEISHA PHARMACEUTICAL CO., LTD.
09 1Nanhai Beisha Pharmaceutical Co. LTD
10 2VALENS MOLECULES PRIVATE LIMITED
11 2Wugan Pharmaceutical (Suzhou) Co., Ltd.
01 4SULFADIAZINE
02 2SULFADIAZINE SODIUM
03 4Sulfadiazine
04 4Sulfadiazine Sodium
01 5China
02 3India
03 2Netherlands
04 4U.S.A
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
NDC Package Code : 62675-0320
Start Marketing Date : 2018-07-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71236-0003
Start Marketing Date : 2017-02-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-707
Start Marketing Date : 2019-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3228
Start Marketing Date : 2021-07-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0705
Start Marketing Date : 2012-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3224
Start Marketing Date : 2022-10-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63422-703
Start Marketing Date : 2015-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63422-707
Start Marketing Date : 2018-06-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62705-0229
Start Marketing Date : 2023-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62705-0230
Start Marketing Date : 2023-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Diazin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diazin, including repackagers and relabelers. The FDA regulates Diazin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diazin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diazin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diazin supplier is an individual or a company that provides Diazin active pharmaceutical ingredient (API) or Diazin finished formulations upon request. The Diazin suppliers may include Diazin API manufacturers, exporters, distributors and traders.
click here to find a list of Diazin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diazin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diazin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diazin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diazin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diazin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diazin suppliers with NDC on PharmaCompass.
We have 9 companies offering Diazin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
